Altered maturation and activation state of circulating monocytes is associated with their enhanced recruitment in pulmonary arterial hypertension
Background It is well-established that patients with pulmonary arterial hypertension (PAH) exhibit increased recruitment of circulating monocytes to their pulmonary arteries. However, it remains unclear whether these monocytes have intrinsic abnormalities that contribute to their recruitment and to...
Saved in:
| Published in | Respiratory research Vol. 26; no. 1; pp. 148 - 19 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
15.04.2025
BioMed Central Ltd Nature Publishing Group BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1465-993X 1465-9921 1465-993X |
| DOI | 10.1186/s12931-025-03182-0 |
Cover
| Summary: | Background
It is well-established that patients with pulmonary arterial hypertension (PAH) exhibit increased recruitment of circulating monocytes to their pulmonary arteries. However, it remains unclear whether these monocytes have intrinsic abnormalities that contribute to their recruitment and to PAH pathogenesis. This study aimed to characterize the gene expression profiles of circulating classical, intermediate, and non-classical monocytes and assess their maturation trajectory in patients with idiopathic (I) PAH compared to control subjects. Additionally, it sought to explore the relationship between the observed IPAH abnormalities and deficiencies in bone morphogenetic receptor 2 (BMPR2), the most frequently mutated gene in PAH, and to assess adhesion and transendothelial migration, key processes in monocyte infiltration of pulmonary arteries.
Methods
Differentially expressed genes and maturation trajectories of circulating monocytes from patients with IPAH vs. control subjects were compared using single cell RNA sequencing (scRNAseq), followed by FACS analysis. Observations from IPAH and control cells were related to reduced
BMPR2
using a THP1 monocyte cell line with
BMPR2
reduced by siRNA as well as induced pluripotent stem cell (iPSC) derived monocytes (iMono) from hereditary (H) PAH patients with a
BMPR2
mutation and monocytes from mice with
Bmpr2
deleted (MON-
Bmpr2
−/−
)
.
Results
Classical IPAH monocytes have decreased
CD14
mRNA leading to a deviation in their maturation trajectory and early terminal fate, which is not rescued by cytokine treatment. Monocytes that evade early cell death show elevated
STAT1
,
PPDPF
and
HLA-B
, and an interferon (IFN) signature indicative of an altered activation state. A strong link between decreased
BMPR2
and
CD14
was observed in THP1 cells and in HPAH iMono with a
BMPR2
mutation associated with
STAT1
and
IFN
related genes, and in monocytes from MON-
Bmpr2
−/−
mice. Increased adhesion to iPSC-derived endothelial cells (iECs) in HPAH-
BMPR2
mutant iMono was associated with elevated ICAM1 expression. Enhanced transendothelial migration of these cells was associated with the reduction in endothelial VE-cadherin (CDH5).
Conclusions
IPAH monocytes exhibit an altered activation state associated with reduced
BMPR2
and
CD14
, along with elevated
STAT1-IFN
expression. These changes are linked to intrinsic functional abnormalities that contribute to the monocytes’ increased propensity to invade the pulmonary circulation. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ISSN: | 1465-993X 1465-9921 1465-993X |
| DOI: | 10.1186/s12931-025-03182-0 |